Ignite Creation Date:
2024-05-05 @ 4:55 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00348894
Status:
TERMINATED
Last Update Posted:
2011-06-01
First Post:
2006-07-04
Brief Title:
SS-Reboxetine Long Term Safety Study In Chronic Painful Diabetic Peripheral Neuropathy
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Phase 2b Long-Term Randomized Open-Label Safety And Tolerability Trial Comparing SS-Reboxetine PNU-165442g With Routine Care In Patients With Chronic Painful Diabetic Peripheral Neuropathy DPN
Status:
TERMINATED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
- Study was terminated due to insufficient clinical efficacy observed in previous studies conducted in postherpetic neuralgia
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the long-term safety and tolerability of SS-Reboxetine in patients with chronic painful diabetic peripheral neuropathy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None